Alnylam Pharmaceuticals, Inc. (ALNY)
239.94
+1.67
(+0.70%)
USD |
NASDAQ |
Sep 16, 14:22
Alnylam Pharmaceuticals Price : 239.94 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 246.99 | 247.42 | 237.44 | 238.27 | 2.175M |
| Sep 14, 2026 | 250.16 | 252.79 | 244.18 | 249.99 | 997229.0 |
| Sep 11, 2026 | 248.05 | 254.08 | 246.01 | 248.68 | 1.177M |
| Sep 10, 2026 | 256.68 | 256.68 | 246.42 | 247.51 | 1.626M |
| Sep 09, 2026 | 257.07 | 261.98 | 253.28 | 258.00 | 1.426M |
| Sep 08, 2026 | 259.00 | 272.08 | 254.00 | 260.10 | 2.009M |
| Sep 04, 2026 | 258.58 | 266.85 | 258.02 | 266.11 | 1.431M |
| Sep 03, 2026 | 265.94 | 271.19 | 261.54 | 264.50 | 1.710M |
| Sep 02, 2026 | 246.48 | 269.94 | 246.48 | 267.40 | 3.286M |
| Sep 01, 2026 | 242.40 | 248.13 | 238.00 | 246.11 | 1.941M |
| Aug 31, 2026 | 235.94 | 243.02 | 233.33 | 240.69 | 1.636M |
| Aug 28, 2026 | 224.46 | 239.08 | 223.61 | 237.10 | 1.847M |
| Aug 27, 2026 | 236.56 | 238.00 | 230.46 | 236.56 | 1.294M |
| Aug 26, 2026 | 238.54 | 242.89 | 236.60 | 239.00 | 1.116M |
| Aug 25, 2026 | 236.56 | 240.67 | 235.41 | 240.08 | 1.576M |
| Aug 24, 2026 | 235.83 | 237.90 | 228.59 | 236.01 | 2.137M |
| Aug 21, 2026 | 228.88 | 238.97 | 228.34 | 236.22 | 1.906M |
| Aug 20, 2026 | 239.00 | 240.88 | 228.74 | 229.30 | 1.702M |
| Aug 19, 2026 | 234.36 | 244.03 | 233.40 | 242.61 | 1.879M |
| Aug 18, 2026 | 226.27 | 230.91 | 222.01 | 228.61 | 1.600M |
| Aug 17, 2026 | 225.76 | 227.99 | 222.12 | 224.60 | 1.539M |
| Aug 14, 2026 | 223.52 | 228.98 | 220.23 | 228.65 | 1.526M |
| Aug 13, 2026 | 225.95 | 227.54 | 222.70 | 227.12 | 1.449M |
| Aug 12, 2026 | 219.00 | 224.66 | 219.00 | 223.95 | 1.621M |
| Aug 11, 2026 | 217.41 | 223.44 | 216.50 | 221.20 | 1.438M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ionis Pharmaceuticals, Inc. | 45.45 |
| BridgeBio Pharma, Inc. | 67.93 |
| Regeneron Pharmaceuticals, Inc. | 778.60 |
| Vertex Pharmaceuticals, Inc. | 515.10 |
| Pfizer Inc. | 27.52 |
Price Related Metrics
| PE Ratio | 40.51 |
| PS Ratio | 6.869 |
| Price to Book Value | 23.70 |
| Price to Free Cash Flow | 41.56 |
| Earnings Yield | 2.47% |
| Market Cap | 32.09B |
| Operating PE Ratio | 33.01 |
| Normalized PE Ratio | 41.69 |